Polianta Ltd Acquires Shares of 10,700 Tenet Healthcare Corporation $THC

Polianta Ltd acquired a new stake in Tenet Healthcare Corporation (NYSE:THC) during the 2nd quarter, Holdings Channel.com reports. The fund acquired 10,700 shares of the company’s stock, valued at approximately $2,001,000. Tenet Healthcare accounts for 0.2% of Polianta Ltd’s portfolio, making the stock its 27th largest holding.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Gradient Investments LLC acquired a new position in Tenet Healthcare in the 2nd quarter valued at about $1,630,000. Baron Wealth Management LLC boosted its holdings in shares of Tenet Healthcare by 15.6% during the second quarter. Baron Wealth Management LLC now owns 1,289 shares of the company’s stock worth $241,000 after acquiring an additional 174 shares during the period. BDF Gestion acquired a new position in shares of Tenet Healthcare in the second quarter valued at approximately $1,673,000. Somerset Trust Co increased its stake in shares of Tenet Healthcare by 7.7% during the second quarter. Somerset Trust Co now owns 2,607 shares of the company’s stock worth $488,000 after purchasing an additional 186 shares during the period. Finally, Parallel Advisors LLC lifted its holdings in Tenet Healthcare by 108.9% during the 1st quarter. Parallel Advisors LLC now owns 1,389 shares of the company’s stock worth $262,000 after purchasing an additional 724 shares during the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

Analysts Set New Price Targets

THC has been the topic of a number of research reports. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $305.00 price objective on shares of Tenet Healthcare in a report on Tuesday, July 28th. Guggenheim upped their price target on shares of Tenet Healthcare from $242.00 to $283.00 and gave the company a “buy” rating in a research note on Tuesday, July 28th. Royal Bank Of Canada raised their price target on shares of Tenet Healthcare from $236.00 to $283.00 and gave the stock an “outperform” rating in a research report on Monday, July 27th. UBS Group boosted their price objective on shares of Tenet Healthcare from $288.00 to $308.00 and gave the company a “buy” rating in a report on Monday, July 27th. Finally, Barclays raised their target price on shares of Tenet Healthcare from $240.00 to $271.00 and gave the stock an “overweight” rating in a report on Friday, July 24th. Seventeen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $271.00.

Tenet Healthcare Trading Up 2.4%

THC opened at $262.75 on Friday. The company has a quick ratio of 1.35, a current ratio of 1.41 and a debt-to-equity ratio of 2.00. Tenet Healthcare Corporation has a twelve month low of $157.58 and a twelve month high of $265.32. The stock has a market capitalization of $21.16 billion, a price-to-earnings ratio of 10.13, a P/E/G ratio of 1.00 and a beta of 1.23. The company has a 50-day simple moving average of $200.19 and a 200 day simple moving average of $201.39.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, beating the consensus estimate of $4.26 by $1.86. The company had revenue of $6.04 billion during the quarter, compared to analysts’ expectations of $5.43 billion. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period in the previous year, the company earned $4.02 EPS. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Analysts predict that Tenet Healthcare Corporation will post 21.09 EPS for the current fiscal year.

Insider Activity

In other Tenet Healthcare news, EVP Paola M. Arbour sold 10,878 shares of the firm’s stock in a transaction on Monday, July 27th. The stock was sold at an average price of $243.90, for a total value of $2,653,144.20. Following the sale, the executive vice president owned 18,413 shares of the company’s stock, valued at approximately $4,490,930.70. This trade represents a 37.14% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Lisa Y. Foo sold 10,000 shares of the business’s stock in a transaction on Wednesday, July 29th. The stock was sold at an average price of $258.03, for a total value of $2,580,300.00. Following the transaction, the executive vice president directly owned 32,053 shares of the company’s stock, valued at $8,270,635.59. This trade represents a 23.78% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 33,953 shares of company stock valued at $7,841,125. Corporate insiders own 0.97% of the company’s stock.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.